WHO ICTRP trial
STUDYING THE POTENTIAL OF HOMEOPATHY AS AN ADJUVANT THERAPY TO STANDARD…
CTRI/2025/09/094985 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/09/094985 |
|---|---|
| Public title | STUDYING THE POTENTIAL OF HOMEOPATHY AS AN ADJUVANT THERAPY TO STANDARD TREATMENT FOR NON-PROLIFERATIVE DIABETIC RETINOPATHY |
| Scientific title | EVALUATING THE EFFICACY OF INDIVIDUALISED TREATMENT IN HOMOEOPATHY AS AN ADJUVANT THERAPY TO STANDARD MEDICAL CARE IN THE MANAGEMENT OF NON-PROLIFERATIVE DIABETIC RETINOPATHY: A SINGLE BLIND, RANDOMIZED CONTROLLED TRIAL - NIL |
| Primary sponsor | NIL |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications |
| Interventions | Intervention1: Individualized Homoeopathic treatment: along with standard medical care, Individualized Homoeopathy remedy prescribed according to classical homeopathic principles after comprehensive case-taking, repertorization with… |
| Registration date | Sep 17, 2025 |
| Target size | 30 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: